Literature DB >> 29659463

Maintaining Short Peripheral Catheter Patency: A Comparison of Saline Lock Versus Continuous Infusion in the Acute Care Setting.

Sheila Serr Roszell1, Holly Barlowe Rabinovich, Cheryl A Smith-Miller.   

Abstract

Sparse evidence exists about how short peripheral catheter (SPC) duration is affected by the presence of a saline lock versus continually infusing fluids. Often the choice to lock an SPC with saline is based on provider preference, rather than available evidence or patient-centered factors. This study compared the duration of 85 SPCs: locked with saline versus continuously running fluids. A secondary analysis considered the influence of a number of intermittent medications and flushes. Although the saline-locked group had a slightly longer duration time, it was not statistically significant. Factors such as desire to ambulate or nighttime saline flushes merit consideration in SPC care decisions and standardized nurse-driven protocols.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29659463     DOI: 10.1097/NAN.0000000000000276

Source DB:  PubMed          Journal:  J Infus Nurs        ISSN: 1533-1458


  3 in total

1.  The flushing procedure in nursing practices: A cross-sectional study with Portuguese and Brazilian nurses.

Authors:  Pedro Parreira; Ricardo Vicente; Rafael A Bernardes; Liliana B Sousa; Beatriz Serambeque; Paulo Costa; Luciene M Braga; Lisete Mónico; Anabela Salgueiro-Oliveira
Journal:  Heliyon       Date:  2020-08-08

2.  The effect of different flushing methods in a short peripheral catheter.

Authors:  Cuiling Tong; Xiaochun Peng; Hong Hu; Zongwen Wang; Hong Zhou
Journal:  Acta Cir Bras       Date:  2019-10-14       Impact factor: 1.388

3.  Randomized clinical trial analyzing maintenance of peripheral venous catheters in an internal medicine unit: Heparin vs. saline.

Authors:  María Jesús Pérez-Granda; Emilio Bouza; Blanca Pinilla; Raquel Cruces; Ariana González; Jesús Millán; María Guembe
Journal:  PLoS One       Date:  2020-01-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.